When hemodiafiltration (HDF) is performed, we can choose the point on the blood circuit where the substitution fluid goes in, i.e. before the diafilter (predilution) or after the diafilter (postdilution). We must avoid unexpected loss of albumin; however, we should remove a certain amount of albumin in order to remove much larger solutes than β2-microglobulin and obtain better clinical outcomes. Previously, ultrafiltration experiments were performed in vitro using aqueous albumin solution and commercial diafilters. The results showed a high sieving coefficient for albumin right after starting the experiment that is identical to several clinical reports. Based on these results, a novel design of the diafilter was attempted for predilution and postdilution HDF. Diafilters for predilution HDF do not require much change in design specifications, employing hollow fibers with a slightly larger diameter in order to reduce high blood pressure caused by the high blood flow rate. Diafilters for postdilution HDF may require much change, including shortening the length in order to reduce the amount of internal filtration. Diafilters specifically designed for predilution or postdilution may be necessary to assure future success of clinical HDF treatment.

1.
Rindi P, Pilone N, Riccò V, Cioni L: Clinical experience with a new hemodiafiltration (HDF) system. ASAIO Trans 1988;34:765-768.
2.
Yamashita AC: New dialysis membrane for removal of middle molecule uremic toxins. Am J Kidney Dis 2001;38:S217-S219.
3.
Ahrenholz PG, Winkler RE, Michelsen A, Lang DA, Bowry SK: Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: the beta2-microglobulin/albumin relationship. Clin Nephrol 2004;62:21-28.
4.
Yamashita AC, Sakurai K: Choice of dialyzers for HDF; in Kawanishi H, Yamashita AC (eds): Hemodiafiltration - A New Era. Contrib Nephrol. Basel, Karger, 2010, vol 168, pp 146-152.
5.
Sakurai K: Biomarkers for evaluation of clinical outcomes of HDF. Blood Purif 2013;31(suppl 1):64-68.
6.
Yamashita AC, Sato T: Central online hemodiafiltration in Japan: management of water quality and practice. Blood Purif 2009;27(suppl 1):50-55.
7.
Tsuchida K: Clinical benefits of pre-dilution on-line HDF. Blood Purif 2013;31(suppl 1):18-22.
8.
Yamashita AC, Tomisawa N: Membrane materials for blood purification in critical care; in Suzuki H, Hirasawa H (eds): Current Progresses in Methodology in Blood Purification in Critical Care. Contrib Nephrol. 2010, vol 166, pp 112-118.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.